Skip to main content

Leverage compliance best practices

Empower due diligence managers, business development leads and functional area experts with a whole new way to work together.

Request a demo
Manage accessThis initiative is privateOnly the initiative owners and authorized users can access the initiative and its opportunities.Make publicOwners and authorized usersSearch users or groupsAddNameAccess levelSBSarah BrooksDefault assignee + OwnerMRMaya RajOwnerDSDaniel SmithOwner

Safeguard confidential data

Protect sensitive data from being leaked, lost or viewed by unauthorized people.

Learn more

Streamline internal processes

Share and collect feedback in a convenient, organized and structured way.

CommentsWrite a commentSend JD John Doe 5 min agoReply That's good to know. What's the current stage of their development, and do they have any existing partnerships? See replies 1 SB Sarah Brooks 5 min agoReply That’s great to know! Let’s set up a meeting with their team to discuss potential collaboration in more detail. , @Daniel @MayaJD John Doe 5 min agoReply , Lorem ipsum dolor sit amet, consectetur adipiscing elit. Donec quis magna sit amet dui accumsan. @SarahDS Daniel Smith 5 min agoReply they're currently focused on Phase II trials, and they haven't entered into any major partnerships yet. , @SarahSee replies 2
FinancialsEditCurrencyUS dollarDeal Value ($)6 210 000Primary KPI to MonitorReturn on InvestmentKPI descripttionProfitability of the in-licensing deal in the European and Asian marketsNPV ($)1 991 000NPV Risk Adjusted ($)1 330 000Peak Sales ($)450 000Upfront Payment300 000

Capture detailed information

With the additional fields features, users can record important information required for successful due diligence, including financial KPIs, asset assessment, and more.

Due diligence best practices from pharma leaders

Consolidate all your opportunity and project data, report on progress and collaborate with your team.

Download the report
“Through due diligence, investors and pharma companies take a closer look at their potential partner, the asset, and the deal itself to validate claims and evaluate risks. With many millions of dollars riding on the success of licensing and acquisition activities, a deal gone wrong can mean significant debt and wasted resources.”
William Vickery
Due Diligence Director, Global Business Development at Servier

Leverage built-in best practices

Access a wide range of complimentary assessment and reporting templates.

Improve alignment and collaboration

Manage the entire process, from inviting the right experts to building reports for decision-making.

Due diligence made simple

Industry-standard assessment templates

Complimentary assessment templates with built-in best practices for small molecule, large molecule, legal compliance, pre-diligence and more.

Email notification templates

Personalize email notifications to keep key internal and external stakeholders updated.

Secure knowledge sharing

Easily share documents and emails exclusively with the involved stakeholders.

Flexible reporting templates

Save time with Inpart's ready-to-use reporting templates, with an option to customize them based on your needs.

User management

Add and manage user roles and permissions for key stakeholders (due diligence managers, multiple experts, etc.) for easier collaboration.

Access control

Ensure compliance by controlling and monitoring who has access. Keep confidential data compliant and secure.

Empower your team with the right tool

Empower your teams with a centralized and secure space, including a wide array of assessment templates based on industry best practices – simplifying and accelerating your due diligence process.

Request a demo

We help bring science to life.

Products
Connect
Deal
Event
Get started
Network
About
Global Challenges
Campaigns
Join the network
Platform
Holistic partnering
Connecting
Networking
Execution
Trust
Security & Compliance
Resources
Blog
Partnering insights
Labiotech.eu
Company
About us
Contact us
© 2025 Inpart Privacy policy Terms of use